Sources

5 Total Sources

Replimune Shares Jump 94% After FDA Panel Backs RP1 Skin Cancer Trial

Left67%
Center33%
CNBC4d ago
Replimune Group Shares Soar 94% After FDA Panel Backs RP1 Skin Cancer Drug Trial
Reuters5d ago
Replimune surges after FDA advisers back skin cancer drug | Reuters
CNBC5d ago
Replimune Group Shares Soar Over 130% Premarket After FDA Panel Favors RP1 Skin Cancer Drug Trial
TipRanks5d ago
Why is Biotech Stock Replimune (REPL) Soaring Over 120% Today? - TipRanks.com
Stocktwits5d ago
Why Is REPL Stock Soaring 127% After Hours Today?